Evaluation of the Applicability of Synthetic Data in the Development of Colorectal Cancer Survival Prediction Models: External Validation of Advanced Machine Learning Models Based on National Cancer Data Center Data - Report - MDSpire

Evaluation of the Applicability of Synthetic Data in the Development of Colorectal Cancer Survival Prediction Models: External Validation of Advanced Machine Learning Models Based on National Cancer Data Center Data

  • By

  • Yujeong Jang

  • Jae Hoon Kwon

  • Heeyong Kim

  • You-Jin Joung

  • Junho ‍Nang

  • Chang Hyun Kim

  • July 7, 2026

  • 0 min

Share

Clinical Report: Assessment of Synthetic Data Utilization for Survival Prediction in CRC

Overview

This study evaluates the clinical applicability of predictive models based on synthetic data for colorectal cancer survival prediction. It quantitatively assesses the effectiveness of models pretrained on synthetic data when applied to actual hospital data.

Background

Colorectal cancer (CRC) is a significant public health issue, necessitating accurate prognostic models to guide treatment decisions. Traditional methods often face limitations due to data privacy and generalizability issues. The use of synthetic data presents a potential solution, allowing for the development and validation of predictive models without privacy constraints.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • Synthetic data can replicate the statistical properties of real clinical data.
  • Domain adaptation techniques can mitigate performance degradation when applying models trained on synthetic data to real clinical data.
  • External validation of predictive models is essential for clinical applicability.
  • Challenges in accessing real-world clinical data limit the development of personalized treatment models.
  • Previous studies have primarily relied on internal validation.

Clinical Implications

External validation is necessary to ensure the reliability of predictive models developed using synthetic data.

Conclusion

The study emphasizes the importance of external validation in clinical settings for predictive models based on synthetic data.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Assessing the Prognostic Significance of Tumor Deposits in Non-Metastatic Lymph Node-Positive Colon Adenocarcinoma Through Cox Regression and Machine Learning Techniques
  2. Author(s)/Org, Source, Year -- Integration of Molecular Signatures from Tumor Deposits Using Machine Learning Enhances Prognostic Assessment in Colon Adenocarcinoma
  3. Author(s)/Org, Source, Year -- Survival prediction in colorectal cancer liver metastases using machine learning with SHAP-based interpretation
  4. The ASCO Post, 2025 -- External Validation Confirms Ability of AI Model to Stratify Recurrence Risk in Early-Stage Lung Cancer
  5. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology - PubMed
  6. Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial - PMC
  7. ESMO basic requirements for AI-based biomarkers in oncology (EBAI) - PubMed
  8. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology - PubMed
  9. Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial - PMC
  10. ESMO basic requirements for AI-based biomarkers in oncology (EBAI) - PubMed

Original Source(s)

Related Content